首页 > 最新文献

Digestive Surgery最新文献

英文 中文
Quality of Life after Minimally Invasive Esophagectomy: A Cross-Sectional Study. 微创食管切除术后生活质量:一项横断面研究。
IF 2.7 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2022-01-01 DOI: 10.1159/000526832
Elke Van Daele, Eefje Stuer, Hanne Vanommeslaeghe, Wim Ceelen, Piet Pattyn, Eva Pape

Introduction: Surgery remains essential in the curative treatment of esophageal cancer (EC), but it is known for its high morbidity and impaired health-related QoL. Minimally invasive esophagectomy (MIE) was introduced to reduce surgical trauma and improve QoL.

Methods: This cross-sectional study aimed to evaluate long-term HRQoL after MIE in comparison with the general population. HRQoL assessment was based on three questionnaires: the European Organisation for Research and Treatment of Cancer (EORTC) Core 30 (QLQ-C30, version 3), the EORTC QLQ Oesophago Gastric 25 (QLQ-OG25), and the Supportive Care Needs Survey-Short Form 34 (SCNS-SF34). Results were compared to a healthy reference population.

Results: One hundred and forty eligible MIE patients were identified, of whom met the inclusion criteria, and 49 completed all questionnaires. Patients reported a significantly better mean score on the global health status and QoL than the healthy reference population (71.5 ± 15.1 vs. 66.1 ± 21.7; p = 0.016). However, patients scored significantly worse about functioning (physical, role, and social) (p < 0.05), fatigue (p = 0.021), eating, dysphagia, pain and discomfort, reflux, appetite loss, weight loss, coughing, and taste (p < 0.001).

Discussion/conclusion: EC survivors can reach a high global health status and QoL at least 1 year after MIE, despite long-term functional, nutritional, and gastrointestinal complaints. Patients provided written informed consent, and the study protocol was approved by the Ethics Committee of Ghent University Hospital (identifier: ID B670201940737).

导言:手术在食管癌(EC)的根治性治疗中仍然是必不可少的,但它以其高发病率和与健康相关的生活质量受损而闻名。采用微创食管切除术(MIE)减少手术创伤,改善患者生活质量。方法:本横断面研究旨在评估MIE后与普通人群的长期HRQoL。HRQoL评估基于三个问卷:欧洲癌症研究和治疗组织(EORTC)核心30 (QLQ- c30,版本3),EORTC QLQ食道胃25 (QLQ- og25)和支持性护理需求调查短表34 (SCNS-SF34)。将结果与健康参考人群进行比较。结果:共筛选出140例符合纳入标准的MIE患者,其中49例完成了全部问卷调查。患者报告的总体健康状况和生活质量的平均得分明显高于健康参考人群(71.5±15.1比66.1±21.7;P = 0.016)。然而,患者在功能(身体、角色和社交)(p < 0.05)、疲劳(p = 0.021)、进食、吞咽困难、疼痛和不适、反流、食欲减退、体重减轻、咳嗽和味觉(p < 0.001)方面得分明显较差。讨论/结论:尽管有长期的功能、营养和胃肠道不适,但EC幸存者在MIE后至少1年仍能达到较高的整体健康状况和生活质量。患者提供书面知情同意,研究方案由根特大学医院伦理委员会(标识符:ID B670201940737)批准。
{"title":"Quality of Life after Minimally Invasive Esophagectomy: A Cross-Sectional Study.","authors":"Elke Van Daele,&nbsp;Eefje Stuer,&nbsp;Hanne Vanommeslaeghe,&nbsp;Wim Ceelen,&nbsp;Piet Pattyn,&nbsp;Eva Pape","doi":"10.1159/000526832","DOIUrl":"https://doi.org/10.1159/000526832","url":null,"abstract":"<p><strong>Introduction: </strong>Surgery remains essential in the curative treatment of esophageal cancer (EC), but it is known for its high morbidity and impaired health-related QoL. Minimally invasive esophagectomy (MIE) was introduced to reduce surgical trauma and improve QoL.</p><p><strong>Methods: </strong>This cross-sectional study aimed to evaluate long-term HRQoL after MIE in comparison with the general population. HRQoL assessment was based on three questionnaires: the European Organisation for Research and Treatment of Cancer (EORTC) Core 30 (QLQ-C30, version 3), the EORTC QLQ Oesophago Gastric 25 (QLQ-OG25), and the Supportive Care Needs Survey-Short Form 34 (SCNS-SF34). Results were compared to a healthy reference population.</p><p><strong>Results: </strong>One hundred and forty eligible MIE patients were identified, of whom met the inclusion criteria, and 49 completed all questionnaires. Patients reported a significantly better mean score on the global health status and QoL than the healthy reference population (71.5 ± 15.1 vs. 66.1 ± 21.7; p = 0.016). However, patients scored significantly worse about functioning (physical, role, and social) (p < 0.05), fatigue (p = 0.021), eating, dysphagia, pain and discomfort, reflux, appetite loss, weight loss, coughing, and taste (p < 0.001).</p><p><strong>Discussion/conclusion: </strong>EC survivors can reach a high global health status and QoL at least 1 year after MIE, despite long-term functional, nutritional, and gastrointestinal complaints. Patients provided written informed consent, and the study protocol was approved by the Ethics Committee of Ghent University Hospital (identifier: ID B670201940737).</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":"39 4","pages":"153-161"},"PeriodicalIF":2.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9121212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to "Identification of Pre-Operative Risk Factors for Poor Survival in Patients with Resectable Pancreatic Cancer Treated with Upfront Surgery". 致 "可切除胰腺癌患者术前生存率低的风险因素识别 "的信
IF 2.7 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2022-01-01 Epub Date: 2022-07-07 DOI: 10.1159/000525832
Harshit Verma, Ashesh Kumar Jha, Manoj Kumar, Prashant Kumar Singh, Anil Kumar, Shiv Shankar Paswan, Deepak Kumar
{"title":"Letter to \"Identification of Pre-Operative Risk Factors for Poor Survival in Patients with Resectable Pancreatic Cancer Treated with Upfront Surgery\".","authors":"Harshit Verma, Ashesh Kumar Jha, Manoj Kumar, Prashant Kumar Singh, Anil Kumar, Shiv Shankar Paswan, Deepak Kumar","doi":"10.1159/000525832","DOIUrl":"10.1159/000525832","url":null,"abstract":"","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":"39 4","pages":"201-202"},"PeriodicalIF":2.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9164480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intake of Acetylsalicylic Acid and High Age Are Risk Factors for Iron Deficiency Anemia in Patients with Large Diaphragmatic Hernias. 大膈疝患者缺铁性贫血的危险因素是乙酰水杨酸摄入和高龄。
IF 2.7 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2022-01-01 DOI: 10.1159/000529326
Christoph G Dietrich, Tanja Kottmann, Annette Holtdirk, Joachim W Heise

Introduction: In 15% of patients with iron deficiency anemia, large diaphragmatic hernias are found as the cause of chronic iron loss. Conversely, iron deficiency anemia is present in 10-40% of diaphragmatic hernia patients. However, it is unclear why some patients with large diaphragmatic hernias develop anemia and others do not.

Methods: We retrospectively analyzed 116 patients with diaphragmatic hernias larger than 5 cm for the presence of anemia and the effect of surgery on this anemia, dividing these patients into 4 groups (group A: 21 patients with anemia/surgery, group B: 27 patients without anemia but with surgery, group C: 34 patients with anemia but without surgery, and group D: 34 patients without anemia/surgery).

Results: Women significantly predominated in the patient population (76%). Patients with iron deficiency anemia tended to be significantly older than patients without iron deficiency anemia (74.7 ± 12.2 vs. 69.6 ± 14.8 years, p = 0.08). The proportion of patients taking ASA was significantly higher in the anemia collective (41.8% vs. 9.8%, p < 0.001). Regression analysis further confirmed that higher age and ASA intake correlated significantly with lower hemoglobin in anemic patients. Performing hernia repair significantly decreased anemia rates and PPI use in the anemia patients, while both remained almost the same in the non-operated anemia patients.

Conclusion: ASA use and advanced age are risk factors for the presence of iron deficiency anemia in patients with large diaphragmatic hernias. Surgical hernia repair is suitable to reduce anemia.

在15%的缺铁性贫血患者中,发现大膈疝是慢性铁流失的原因。相反,10-40%的膈疝患者存在缺铁性贫血。然而,目前尚不清楚为什么有些大膈疝患者会发生贫血,而另一些则不会。方法:回顾性分析116例大于5 cm膈疝存在贫血及手术治疗对贫血的影响,将患者分为4组(A组:有贫血/手术21例,B组:无贫血但手术27例,C组:有贫血但不手术34例,D组:无贫血/手术34例)。结果:女性在患者群体中占明显优势(76%)。缺铁性贫血患者明显大于无缺铁性贫血患者(74.7±12.2∶69.6±14.8岁,p = 0.08)。在贫血组中,服用ASA的患者比例明显高于对照组(41.8% vs. 9.8%, p < 0.001)。回归分析进一步证实,年龄增大和ASA摄入与贫血患者血红蛋白降低显著相关。行疝修补术显著降低贫血患者的贫血率和PPI的使用,而在未手术的贫血患者中两者几乎保持不变。结论:ASA的使用和高龄是大膈疝患者缺铁性贫血的危险因素。外科疝修补术适合减少贫血。
{"title":"Intake of Acetylsalicylic Acid and High Age Are Risk Factors for Iron Deficiency Anemia in Patients with Large Diaphragmatic Hernias.","authors":"Christoph G Dietrich,&nbsp;Tanja Kottmann,&nbsp;Annette Holtdirk,&nbsp;Joachim W Heise","doi":"10.1159/000529326","DOIUrl":"https://doi.org/10.1159/000529326","url":null,"abstract":"<p><strong>Introduction: </strong>In 15% of patients with iron deficiency anemia, large diaphragmatic hernias are found as the cause of chronic iron loss. Conversely, iron deficiency anemia is present in 10-40% of diaphragmatic hernia patients. However, it is unclear why some patients with large diaphragmatic hernias develop anemia and others do not.</p><p><strong>Methods: </strong>We retrospectively analyzed 116 patients with diaphragmatic hernias larger than 5 cm for the presence of anemia and the effect of surgery on this anemia, dividing these patients into 4 groups (group A: 21 patients with anemia/surgery, group B: 27 patients without anemia but with surgery, group C: 34 patients with anemia but without surgery, and group D: 34 patients without anemia/surgery).</p><p><strong>Results: </strong>Women significantly predominated in the patient population (76%). Patients with iron deficiency anemia tended to be significantly older than patients without iron deficiency anemia (74.7 ± 12.2 vs. 69.6 ± 14.8 years, p = 0.08). The proportion of patients taking ASA was significantly higher in the anemia collective (41.8% vs. 9.8%, p < 0.001). Regression analysis further confirmed that higher age and ASA intake correlated significantly with lower hemoglobin in anemic patients. Performing hernia repair significantly decreased anemia rates and PPI use in the anemia patients, while both remained almost the same in the non-operated anemia patients.</p><p><strong>Conclusion: </strong>ASA use and advanced age are risk factors for the presence of iron deficiency anemia in patients with large diaphragmatic hernias. Surgical hernia repair is suitable to reduce anemia.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":"39 5-6","pages":"250-254"},"PeriodicalIF":2.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9366653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of the First Assistant on Anastomotic Leakage after Rectal Cancer Surgery with Double-Stapling Anastomosis: A Propensity Score Matching Analysis. 第一辅助对直肠癌双吻合器吻合术后吻合口漏的影响:倾向评分匹配分析。
IF 2.7 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2022-01-01 DOI: 10.1159/000525909
Soo Young Lee, Sola Lee, Ook Song, Jaram Lee, Hyeong-Min Park, Chang Hyun Kim, Hyeong Rok Kim

Introduction: Proper handling and firing of the circular stapler are important for secure anastomosis in rectal cancer surgery. This study aimed to investigate the association between the first assistant and anastomotic leakage (AL) after rectal cancer surgery with double-stapling anastomosis.

Methods: Patients with primary rectal cancer who underwent low anterior resection with double-stapling anastomosis between January 2015 and September 2019 were included. Data on clinicopathological characteristics, including the first assistant's sex and experience level, were retrospectively reviewed, and the risk factors for AL were analyzed using propensity score matching analysis.

Results: Among 758 rectal cancer surgeries, residents participated in 401 (52.9%) surgeries, and fellows participated in 357 (47.1%) surgeries as first assistants. After propensity score matching (n = 650), AL occurred in 5.4% (35/650). The first assistant's experience level (resident: 5.5% vs. fellow: 5.2%, p = 0.862) and sex (male: 5.4% vs. female: 4.9%, p = 0.849) were not associated with the occurrence of AL. Male sex in patients was the only significant predictive factor for AL (odds ratio = 2.804, 95% confidence interval 1.070-7.351, p = 0.036).

Discussion/conclusion: The first assistant's sex and experience level were not associated with AL after rectal cancer surgery with double-stapling anastomosis. These findings may justify resident participation in rectal cancer surgeries in which circular staplers are used.

导读:在直肠癌手术中,环形吻合器的正确使用和发射是保证吻合安全的重要因素。本研究旨在探讨直肠癌双吻合器术后第一辅助与吻合口漏(AL)的关系。方法:选取2015年1月至2019年9月行双吻合器低位前切除术的原发性直肠癌患者。回顾性回顾临床病理特征数据,包括第一助理的性别和经验水平,并使用倾向评分匹配分析分析AL的危险因素。结果:758例直肠癌手术中,住院医师以第一助理的身份参与401例(52.9%),研究员以第一助理的身份参与357例(47.1%)。倾向评分匹配(n = 650)后,AL发生率为5.4%(35/650)。第一助理的经验水平(住院医师:5.5%对同行:5.2%,p = 0.862)和性别(男性:5.4%对女性:4.9%,p = 0.849)与AL的发生无关,患者的男性是AL发生的唯一显著预测因素(优势比= 2.804,95%可信区间1.070 ~ 7.351,p = 0.036)。讨论/结论:直肠癌双吻合器术后第一助理的性别和经验水平与AL无关。这些发现可能证明居民参与使用圆形订书机的直肠癌手术是合理的。
{"title":"Effect of the First Assistant on Anastomotic Leakage after Rectal Cancer Surgery with Double-Stapling Anastomosis: A Propensity Score Matching Analysis.","authors":"Soo Young Lee,&nbsp;Sola Lee,&nbsp;Ook Song,&nbsp;Jaram Lee,&nbsp;Hyeong-Min Park,&nbsp;Chang Hyun Kim,&nbsp;Hyeong Rok Kim","doi":"10.1159/000525909","DOIUrl":"https://doi.org/10.1159/000525909","url":null,"abstract":"<p><strong>Introduction: </strong>Proper handling and firing of the circular stapler are important for secure anastomosis in rectal cancer surgery. This study aimed to investigate the association between the first assistant and anastomotic leakage (AL) after rectal cancer surgery with double-stapling anastomosis.</p><p><strong>Methods: </strong>Patients with primary rectal cancer who underwent low anterior resection with double-stapling anastomosis between January 2015 and September 2019 were included. Data on clinicopathological characteristics, including the first assistant's sex and experience level, were retrospectively reviewed, and the risk factors for AL were analyzed using propensity score matching analysis.</p><p><strong>Results: </strong>Among 758 rectal cancer surgeries, residents participated in 401 (52.9%) surgeries, and fellows participated in 357 (47.1%) surgeries as first assistants. After propensity score matching (n = 650), AL occurred in 5.4% (35/650). The first assistant's experience level (resident: 5.5% vs. fellow: 5.2%, p = 0.862) and sex (male: 5.4% vs. female: 4.9%, p = 0.849) were not associated with the occurrence of AL. Male sex in patients was the only significant predictive factor for AL (odds ratio = 2.804, 95% confidence interval 1.070-7.351, p = 0.036).</p><p><strong>Discussion/conclusion: </strong>The first assistant's sex and experience level were not associated with AL after rectal cancer surgery with double-stapling anastomosis. These findings may justify resident participation in rectal cancer surgeries in which circular staplers are used.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":"39 4","pages":"176-182"},"PeriodicalIF":2.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10568669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EDS Society News EDS社新闻
IF 2.7 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2022-01-01 DOI: 10.1159/000520690
{"title":"EDS Society News","authors":"","doi":"10.1159/000520690","DOIUrl":"https://doi.org/10.1159/000520690","url":null,"abstract":"","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":"38 1","pages":"378 - 378"},"PeriodicalIF":2.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47250916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of Celiac Neurolysis and Splanchnicectomy on Survival in Unresectable Pancreatic Cancer: A Systematic Review and Meta-Analysis. 腹腔神经松解术和胰切除术对不可切除胰腺癌患者生存的影响:系统回顾和荟萃分析。
IF 2.7 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2022-01-01 Epub Date: 2021-12-10 DOI: 10.1159/000520456
Linhan Ye, Stephan Schorn, Ilaria Pergolini, Okan Safak, Elke Demir, Rouzanna Istvanffy, Helmut Friess, Güralp O Ceyhan, Ihsan Ekin Demir

Background: Intractable pancreatic pain is one of the most common symptoms of patients with pancreatic ductal adenocarcinoma (PDAC). Celiac neurolysis (CN) and splanchnicectomy were already described as effective methods to manage abdominal pain in unresectable PDAC, but their impact on overall survival (OS) has not yet been established.

Objective: We aimed to investigate the impact of CN and splanchnicectomy on the survival of patients with unresectable pancreatic cancer.

Methods: A systematic review of PubMed and Cochrane Library according to predefined searching terms was conducted in March 2020. Hazard ratios (HR) of OS data were calculated using the Mantel-Haenszel model for random effects or fixed effects.

Result: Four randomized-controlled trials (RCTs) and 2 non-RCTs with a total of 2,507 patients were identified. The overall pooled HR did not reveal any relevant effect of CN and splanchnicectomy on OS (HR: 1.03; 95% CI: 0.81-1.32), which was also underlined by the sensitivity analysis of RCTs (HR: 1.0; 95% CI: 0.72-1.39) and non-RCTs (HR: 1.07; 95% CI: 0.71-1.63). However, subgroup analyses depending on tumor stage revealed that CN or splanchnicectomy was associated with a worsened OS in AJCC (American Joint Committee on Cancer) stage III patients with unresectable PDAC (HR: 1.22; 95% CI: 1.03-1.45), but nor for AJCC stage IV patients (HR: 1.27; 95% CI: 0.9-1.80).

Conclusion: Although only few data are currently available, this systematic review with meta-analysis showed that in unresectable PDAC, CN or splanchnicectomy is associated with a worsened survival in stage III PDAC patients, with no effect on stage IV PDAC patients. These data call for caution in the usage of CN or splanchnicectomy in stage III PDAC and for further studies addressing this observation.

背景:顽固性胰腺疼痛是胰腺导管腺癌(PDAC)患者最常见的症状之一。腹腔神经松解术(CN)和内脏切除术已经被描述为治疗不可切除PDAC患者腹痛的有效方法,但它们对总生存期(OS)的影响尚未确定。目的:探讨CN和胰切除术对不能切除的胰腺癌患者生存的影响。方法:于2020年3月根据预设检索词对PubMed和Cochrane Library进行系统综述。随机效应和固定效应采用Mantel-Haenszel模型计算OS数据的风险比(HR)。结果:共纳入4项随机对照试验(rct)和2项非随机对照试验(rct),共2507例患者。总体合并的HR未显示CN和内脏切除术对OS有任何相关影响(HR: 1.03;95% CI: 0.81-1.32), rct的敏感性分析也强调了这一点(HR: 1.0;95% CI: 0.72-1.39)和非rct (HR: 1.07;95% ci: 0.71-1.63)。然而,根据肿瘤分期的亚组分析显示,CN或内脏切除术与AJCC(美国癌症联合委员会)III期不可切除PDAC患者的OS恶化相关(HR: 1.22;95% CI: 1.03-1.45),但AJCC IV期患者没有(HR: 1.27;95% ci: 0.9-1.80)。结论:尽管目前可用的数据很少,但本系统综述与荟萃分析显示,在不可切除的PDAC中,CN或内脏切除术与III期PDAC患者的生存恶化相关,而对IV期PDAC患者没有影响。这些数据呼吁在III期PDAC中谨慎使用CN或内脏切除术,并进一步研究这一观察结果。
{"title":"The Effect of Celiac Neurolysis and Splanchnicectomy on Survival in Unresectable Pancreatic Cancer: A Systematic Review and Meta-Analysis.","authors":"Linhan Ye,&nbsp;Stephan Schorn,&nbsp;Ilaria Pergolini,&nbsp;Okan Safak,&nbsp;Elke Demir,&nbsp;Rouzanna Istvanffy,&nbsp;Helmut Friess,&nbsp;Güralp O Ceyhan,&nbsp;Ihsan Ekin Demir","doi":"10.1159/000520456","DOIUrl":"https://doi.org/10.1159/000520456","url":null,"abstract":"<p><strong>Background: </strong>Intractable pancreatic pain is one of the most common symptoms of patients with pancreatic ductal adenocarcinoma (PDAC). Celiac neurolysis (CN) and splanchnicectomy were already described as effective methods to manage abdominal pain in unresectable PDAC, but their impact on overall survival (OS) has not yet been established.</p><p><strong>Objective: </strong>We aimed to investigate the impact of CN and splanchnicectomy on the survival of patients with unresectable pancreatic cancer.</p><p><strong>Methods: </strong>A systematic review of PubMed and Cochrane Library according to predefined searching terms was conducted in March 2020. Hazard ratios (HR) of OS data were calculated using the Mantel-Haenszel model for random effects or fixed effects.</p><p><strong>Result: </strong>Four randomized-controlled trials (RCTs) and 2 non-RCTs with a total of 2,507 patients were identified. The overall pooled HR did not reveal any relevant effect of CN and splanchnicectomy on OS (HR: 1.03; 95% CI: 0.81-1.32), which was also underlined by the sensitivity analysis of RCTs (HR: 1.0; 95% CI: 0.72-1.39) and non-RCTs (HR: 1.07; 95% CI: 0.71-1.63). However, subgroup analyses depending on tumor stage revealed that CN or splanchnicectomy was associated with a worsened OS in AJCC (American Joint Committee on Cancer) stage III patients with unresectable PDAC (HR: 1.22; 95% CI: 1.03-1.45), but nor for AJCC stage IV patients (HR: 1.27; 95% CI: 0.9-1.80).</p><p><strong>Conclusion: </strong>Although only few data are currently available, this systematic review with meta-analysis showed that in unresectable PDAC, CN or splanchnicectomy is associated with a worsened survival in stage III PDAC patients, with no effect on stage IV PDAC patients. These data call for caution in the usage of CN or splanchnicectomy in stage III PDAC and for further studies addressing this observation.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":"39 1","pages":"51-59"},"PeriodicalIF":2.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39599589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgery in Autoimmune Pancreatitis. 自身免疫性胰腺炎的手术治疗
IF 2.7 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2022-01-01 Epub Date: 2021-12-15 DOI: 10.1159/000521490
Sara Nikolic, Poya Ghorbani, Raffaella Pozzi Mucelli, Sam Ghazi, Francisco Baldaque-Silva, Marco Del Chiaro, Ernesto Sparrelid, Caroline S Verbeke, J-Matthias Löhr, Miroslav Vujasinovic

Introduction: Autoimmune pancreatitis (AIP) is a disease that may mimic malignant pancreatic lesions both in terms of symptomatology and imaging appearance. The aim of the present study is to analyze experiences of surgery in patients with AIP in one of the largest European cohorts.

Patients and methods: We performed a single-center retrospective study of patients diagnosed with AIP at the Department of Abdominal Diseases at Karolinska University Hospital in Stockholm, Sweden, between January 2001 and October 2020.

Results: There were 159 patients diagnosed with AIP, and among them, 35 (22.0%) patients had surgery: 20 (57.1%) males and 15 (42.9%) females; median age at surgery was 59 years (range 37-81). Median follow-up period after surgery was 50 months (range 1-235). AIP type 1 was diagnosed in 28 (80%) patients and AIP type 2 in 7 (20%) patients. Malignant and premalignant lesions were diagnosed in 8 (22.9%) patients for whom AIP was not the primary differential diagnosis, but in all cases, it was described as a simultaneous finding and recorded in retrospective analysis in histological reports of surgical specimens.

Conclusions: Diagnosis of AIP is not always straightforward, and in some cases, it is not easy to differentiate it from the malignancy. Surgery is generally not indicated for AIP but might be considered in patients when suspicion of malignant/premalignant lesions cannot be excluded after complete diagnostic workup.

自身免疫性胰腺炎(AIP)是一种在症状和影像学表现上都与胰腺恶性病变相似的疾病。本研究的目的是分析欧洲最大的队列之一的AIP患者的手术经验。患者和方法:我们对2001年1月至2020年10月期间在瑞典斯德哥尔摩卡罗林斯卡大学医院腹部疾病科诊断为AIP的患者进行了一项单中心回顾性研究。结果:诊断为AIP的患者159例,其中手术35例(22.0%),其中男性20例(57.1%),女性15例(42.9%);手术中位年龄为59岁(范围37-81岁)。术后中位随访时间为50个月(范围1-235)。1型AIP 28例(80%),2型AIP 7例(20%)。8例(22.9%)AIP不是主要鉴别诊断的患者被诊断为恶性和癌前病变,但在所有病例中,AIP都被描述为同时发现,并在手术标本的组织学报告中进行回顾性分析。结论:AIP的诊断并不总是直截了当的,在某些情况下,不容易与恶性肿瘤区分。AIP通常不需要手术治疗,但在完整的诊断检查后不能排除疑似恶性/癌前病变的患者可以考虑手术治疗。
{"title":"Surgery in Autoimmune Pancreatitis.","authors":"Sara Nikolic,&nbsp;Poya Ghorbani,&nbsp;Raffaella Pozzi Mucelli,&nbsp;Sam Ghazi,&nbsp;Francisco Baldaque-Silva,&nbsp;Marco Del Chiaro,&nbsp;Ernesto Sparrelid,&nbsp;Caroline S Verbeke,&nbsp;J-Matthias Löhr,&nbsp;Miroslav Vujasinovic","doi":"10.1159/000521490","DOIUrl":"https://doi.org/10.1159/000521490","url":null,"abstract":"<p><strong>Introduction: </strong>Autoimmune pancreatitis (AIP) is a disease that may mimic malignant pancreatic lesions both in terms of symptomatology and imaging appearance. The aim of the present study is to analyze experiences of surgery in patients with AIP in one of the largest European cohorts.</p><p><strong>Patients and methods: </strong>We performed a single-center retrospective study of patients diagnosed with AIP at the Department of Abdominal Diseases at Karolinska University Hospital in Stockholm, Sweden, between January 2001 and October 2020.</p><p><strong>Results: </strong>There were 159 patients diagnosed with AIP, and among them, 35 (22.0%) patients had surgery: 20 (57.1%) males and 15 (42.9%) females; median age at surgery was 59 years (range 37-81). Median follow-up period after surgery was 50 months (range 1-235). AIP type 1 was diagnosed in 28 (80%) patients and AIP type 2 in 7 (20%) patients. Malignant and premalignant lesions were diagnosed in 8 (22.9%) patients for whom AIP was not the primary differential diagnosis, but in all cases, it was described as a simultaneous finding and recorded in retrospective analysis in histological reports of surgical specimens.</p><p><strong>Conclusions: </strong>Diagnosis of AIP is not always straightforward, and in some cases, it is not easy to differentiate it from the malignancy. Surgery is generally not indicated for AIP but might be considered in patients when suspicion of malignant/premalignant lesions cannot be excluded after complete diagnostic workup.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":"39 1","pages":"32-41"},"PeriodicalIF":2.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985041/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39608479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Endoscopic Stenting for Malignant Left-Sided Large-Bowel Obstruction in Patients with Colorectal Cancer: Evaluation according to Pathological Stage. 内镜下支架置入术治疗大肠癌左侧恶性大肠梗阻:病理分期评价。
IF 2.7 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2022-01-01 DOI: 10.1159/000528181
Yoon Oh, Sunseok Yoon, Sun Gyo Lim, Seung Yeop Oh

Introduction: Self-expandable metallic stents (SEMSs) are widely used in patients with malignant left-sided large-bowel obstruction (MLLO) to convert an emergency situation into an elective one. However, the effects of endoscopic stenting on oncological outcomes remain unclear. This study aimed to analyze the oncological outcomes of SEMS placement in patients with MLLO stratified by pathological stage.

Methods: We reviewed the data of patients with MLLO that were prospectively collected between January 2005 and December 2016. Patients were divided into those who underwent SEMS placement as a bridge to surgery and those who underwent emergency surgery. Disease-free survival (DFS) and overall survival (OS) were compared between groups, and their prognostic factors were determined by pathological stage.

Results: SEMS placement and emergency surgery were performed in 130 and 45 patients, respectively. There was no difference in the 5-year DFS and OS rate between two groups. Subgroup analysis revealed a significant difference in the 5-year DFS and OS rate in patients with stage III MLLO, but was not observed in patients with stage II MLLO. Multivariate Cox regression analysis for stage III MLLO revealed endoscopic stenting (hazard ratio [HR], 2.051; 95% confidence interval [CI], 1.018-4.131; p = 0.044) as the only prognostic factor for DFS. Age, tumor differentiation, perineural invasion, and endoscopic stenting (HR, 3.189; 95% CI, 1.346-7.556; p = 0.008) were prognostic factors for OS.

Conclusion: In terms of oncologic outcomes, endoscopic stenting might be more beneficial than ES in patients with stage III MLLO.

自膨胀金属支架(SEMSs)广泛应用于恶性左侧大肠梗阻(MLLO)患者,将紧急情况转化为选择性情况。然而,内镜支架置入术对肿瘤预后的影响尚不清楚。本研究旨在分析按病理分期分层放置SEMS的MLLO患者的肿瘤学结果。方法:回顾2005年1月至2016年12月前瞻性收集的MLLO患者资料。患者被分为两组,一组接受SEMS安置作为手术的桥梁,另一组接受紧急手术。比较两组间无病生存期(DFS)和总生存期(OS),并根据病理分期确定预后因素。结果:分别对130例和45例患者进行了SEMS安置和急诊手术。两组患者的5年DFS和OS率无差异。亚组分析显示,III期MLLO患者的5年DFS和OS率有显著差异,但在II期MLLO患者中未观察到。多因素Cox回归分析显示III期MLLO患者需要内镜支架植入术(风险比[HR], 2.051;95%置信区间[CI], 1.018-4.131;p = 0.044)作为DFS的唯一预后因素。年龄、肿瘤分化、神经周围侵犯和内镜支架植入术(HR, 3.189;95% ci, 1.346-7.556;p = 0.008)为OS的预后因素。结论:在肿瘤预后方面,内镜下支架置入可能比ES更有利于III期MLLO患者。
{"title":"Endoscopic Stenting for Malignant Left-Sided Large-Bowel Obstruction in Patients with Colorectal Cancer: Evaluation according to Pathological Stage.","authors":"Yoon Oh,&nbsp;Sunseok Yoon,&nbsp;Sun Gyo Lim,&nbsp;Seung Yeop Oh","doi":"10.1159/000528181","DOIUrl":"https://doi.org/10.1159/000528181","url":null,"abstract":"<p><strong>Introduction: </strong>Self-expandable metallic stents (SEMSs) are widely used in patients with malignant left-sided large-bowel obstruction (MLLO) to convert an emergency situation into an elective one. However, the effects of endoscopic stenting on oncological outcomes remain unclear. This study aimed to analyze the oncological outcomes of SEMS placement in patients with MLLO stratified by pathological stage.</p><p><strong>Methods: </strong>We reviewed the data of patients with MLLO that were prospectively collected between January 2005 and December 2016. Patients were divided into those who underwent SEMS placement as a bridge to surgery and those who underwent emergency surgery. Disease-free survival (DFS) and overall survival (OS) were compared between groups, and their prognostic factors were determined by pathological stage.</p><p><strong>Results: </strong>SEMS placement and emergency surgery were performed in 130 and 45 patients, respectively. There was no difference in the 5-year DFS and OS rate between two groups. Subgroup analysis revealed a significant difference in the 5-year DFS and OS rate in patients with stage III MLLO, but was not observed in patients with stage II MLLO. Multivariate Cox regression analysis for stage III MLLO revealed endoscopic stenting (hazard ratio [HR], 2.051; 95% confidence interval [CI], 1.018-4.131; p = 0.044) as the only prognostic factor for DFS. Age, tumor differentiation, perineural invasion, and endoscopic stenting (HR, 3.189; 95% CI, 1.346-7.556; p = 0.008) were prognostic factors for OS.</p><p><strong>Conclusion: </strong>In terms of oncologic outcomes, endoscopic stenting might be more beneficial than ES in patients with stage III MLLO.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":"39 5-6","pages":"242-249"},"PeriodicalIF":2.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9366793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lower Incidence of Postoperative Urinary Retention in Robotic Total Mesorectal Excision for Low Rectal Cancer Compared with Laparoscopic Surgery. 与腹腔镜手术相比,低位直肠癌机器人全肠系膜切除术术后尿潴留发生率较低。
IF 2.7 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2022-01-01 Epub Date: 2022-02-07 DOI: 10.1159/000522229
Tae Hoon Lee, Jung-Myun Kwak, Da Young Yu, Kyung-Sook Yang, Se Jin Baek, Jin Kim, Seon Hahn Kim

Introduction: The incidence and clinical significance of postoperative urinary retention (POUR) remain high. This study aimed to evaluate the incidence of POUR and related risk factors in patients who underwent total mesorectal excision (TMR) for low rectal cancer.

Methods: This study is a retrospective review of a prospectively collected colorectal database from a single center. Data from patients who underwent surgery for low rectal cancer between September 2006 and May 2017 were analyzed to assess the risk factors of POUR. POUR was considered inability to void after urinary catheter removal requiring catheter reinsertion and difficulty in bladder emptying requiring intermittent catheterization.

Results: Of 555 patients with low rectal cancer, 78 (14.1%) developed POUR. Based on multivariate logistic regression analysis, laparoscopic TMR (odds ratio [OR]; 2.114, 95% confidence interval [CI]; 1.212-3.689, p = 0.008) and postoperative ileus (OR; 2.389, 95% CI; 1.282-4.450, p = 0.006) were independent risk factors of POUR. Male gender, advanced age, neoadjuvant chemoradiation, longer operative time, abdominoperineal resection, and lateral pelvic lymph node dissection were not associated with POUR. Advanced age over 65 years also failed to show statistical significance (OR; 1.604, 95% CI; 0.965-2.668, p = 0.068).

Conclusion: Laparoscopic approach and postoperative ileus are risk factors for POUR after low rectal cancer surgery. We postulate that the benefits of robotic surgical systems compared to a laparoscopic approach may reduce the incidence of POUR.

导读:术后尿潴留(POUR)的发生率和临床意义居高不下。本研究旨在评估低位直肠癌行全肠系膜切除术(TMR)患者的POUR发生率及相关危险因素。方法:本研究是对一个单一中心前瞻性收集的结直肠数据库进行回顾性分析。分析了2006年9月至2017年5月期间接受低位直肠癌手术的患者的数据,以评估POUR的危险因素。POUR被认为在拔出导尿管后不能排空,需要重新插入导尿管,膀胱排空困难,需要间歇性导尿。结果:555例低位直肠癌患者中,78例(14.1%)发生POUR。基于多因素logistic回归分析,腹腔镜TMR(比值比[OR];2.114, 95%置信区间[CI];1.212-3.689, p = 0.008)和术后肠梗阻(OR;2.389, 95% ci;1.282 ~ 4.450 (p = 0.006)是POUR的独立危险因素。男性、高龄、新辅助放化疗、手术时间较长、腹部会阴切除、盆腔外侧淋巴结清扫与POUR无关。65岁以上的高龄患者也没有统计学意义(OR;1.604, 95% ci;0.965-2.668, p = 0.068)。结论:腹腔镜入路和术后肠梗阻是低位直肠癌术后发生POUR的危险因素。我们假设机器人手术系统与腹腔镜方法相比的好处可能会减少POUR的发生率。
{"title":"Lower Incidence of Postoperative Urinary Retention in Robotic Total Mesorectal Excision for Low Rectal Cancer Compared with Laparoscopic Surgery.","authors":"Tae Hoon Lee,&nbsp;Jung-Myun Kwak,&nbsp;Da Young Yu,&nbsp;Kyung-Sook Yang,&nbsp;Se Jin Baek,&nbsp;Jin Kim,&nbsp;Seon Hahn Kim","doi":"10.1159/000522229","DOIUrl":"https://doi.org/10.1159/000522229","url":null,"abstract":"<p><strong>Introduction: </strong>The incidence and clinical significance of postoperative urinary retention (POUR) remain high. This study aimed to evaluate the incidence of POUR and related risk factors in patients who underwent total mesorectal excision (TMR) for low rectal cancer.</p><p><strong>Methods: </strong>This study is a retrospective review of a prospectively collected colorectal database from a single center. Data from patients who underwent surgery for low rectal cancer between September 2006 and May 2017 were analyzed to assess the risk factors of POUR. POUR was considered inability to void after urinary catheter removal requiring catheter reinsertion and difficulty in bladder emptying requiring intermittent catheterization.</p><p><strong>Results: </strong>Of 555 patients with low rectal cancer, 78 (14.1%) developed POUR. Based on multivariate logistic regression analysis, laparoscopic TMR (odds ratio [OR]; 2.114, 95% confidence interval [CI]; 1.212-3.689, p = 0.008) and postoperative ileus (OR; 2.389, 95% CI; 1.282-4.450, p = 0.006) were independent risk factors of POUR. Male gender, advanced age, neoadjuvant chemoradiation, longer operative time, abdominoperineal resection, and lateral pelvic lymph node dissection were not associated with POUR. Advanced age over 65 years also failed to show statistical significance (OR; 1.604, 95% CI; 0.965-2.668, p = 0.068).</p><p><strong>Conclusion: </strong>Laparoscopic approach and postoperative ileus are risk factors for POUR after low rectal cancer surgery. We postulate that the benefits of robotic surgical systems compared to a laparoscopic approach may reduce the incidence of POUR.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":"39 2-3","pages":"75-82"},"PeriodicalIF":2.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39773510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Laparoscopic versus Open Approach for Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction: A Systematic Review and Meta-Analysis. 腹腔镜与开放入路治疗食管胃交界处Siewert II/III型腺癌:一项系统综述和meta分析
IF 2.7 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2022-01-01 DOI: 10.1159/000528912
Ming Wu, Wei Zhang, Yan-Yang Song

Introduction: Due to the specific location, the potential advantages of laparoscopic gastrectomy (LG) compared with open gastrectomy (OG) for Siewert II/III adenocarcinoma of the esophagogastric junction (AEG) remain uncertain. The current study aimed to compare the short- and long-term outcomes of LG versus OG in treating Siewert type II/III adenocarcinoma.

Methods: We searched PubMed, Embase, Web of Science, MEDLINE (hosted by Ovid), and the Cochrane Library for publications till July 2022 and then used the RevMan 5.3 software for statistical analysis.

Results: Ten publications from 10 medical centers were included, with 1,516 cases from the LG group and 1,219 from the OG group. Meta-analysis results showed that the LG group was superior to the OG group in intraoperative blood loss, hospital stay, lymph nodes retrieved, time to ambulation, time to first flatus, time to diet, 5-year overall survival, and 5-year disease-free survival. There was no significant difference between the two groups in operative time, overall complications, proximal margin, distal margin, pulmonary infection, anastomotic leakage, mortality, ileus, or absolute infection.

Conclusions: Compared with OG, LG is associated with better surgical and long-term outcomes in Siewert type II/III AEG. LG is a safe and feasible option for treating Siewert type II/III AEG. However, studies with large sample sizes, long follow-up periods, and rigorous designs are needed for verification.

导言:由于位置的特殊性,对于食管胃交界处siwert II/III型腺癌(AEG),腹腔镜胃切除术(LG)与开放式胃切除术(OG)相比的潜在优势尚不确定。目前的研究旨在比较LG和OG治疗siwert II/III型腺癌的短期和长期结果。方法:检索PubMed、Embase、Web of Science、MEDLINE(由Ovid托管)和Cochrane Library,检索截止到2022年7月的出版物,使用RevMan 5.3软件进行统计分析。结果:纳入来自10个医疗中心的10篇出版物,其中LG组1516例,OG组1219例。荟萃分析结果显示,LG组术中出血量、住院时间、淋巴结清扫、下床时间、首次排气时间、饮食时间、5年总生存期和5年无病生存期均优于OG组。两组在手术时间、总并发症、近缘、远缘、肺部感染、吻合口漏、死亡率、肠梗阻、绝对感染等方面无显著差异。结论:与OG相比,LG在Siewert II/III型AEG中具有更好的手术和长期预后。LG是治疗Siewert II/III型AEG的一种安全可行的选择。然而,研究样本量大,随访时间长,设计严谨,需要验证。
{"title":"Laparoscopic versus Open Approach for Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction: A Systematic Review and Meta-Analysis.","authors":"Ming Wu,&nbsp;Wei Zhang,&nbsp;Yan-Yang Song","doi":"10.1159/000528912","DOIUrl":"https://doi.org/10.1159/000528912","url":null,"abstract":"<p><strong>Introduction: </strong>Due to the specific location, the potential advantages of laparoscopic gastrectomy (LG) compared with open gastrectomy (OG) for Siewert II/III adenocarcinoma of the esophagogastric junction (AEG) remain uncertain. The current study aimed to compare the short- and long-term outcomes of LG versus OG in treating Siewert type II/III adenocarcinoma.</p><p><strong>Methods: </strong>We searched PubMed, Embase, Web of Science, MEDLINE (hosted by Ovid), and the Cochrane Library for publications till July 2022 and then used the RevMan 5.3 software for statistical analysis.</p><p><strong>Results: </strong>Ten publications from 10 medical centers were included, with 1,516 cases from the LG group and 1,219 from the OG group. Meta-analysis results showed that the LG group was superior to the OG group in intraoperative blood loss, hospital stay, lymph nodes retrieved, time to ambulation, time to first flatus, time to diet, 5-year overall survival, and 5-year disease-free survival. There was no significant difference between the two groups in operative time, overall complications, proximal margin, distal margin, pulmonary infection, anastomotic leakage, mortality, ileus, or absolute infection.</p><p><strong>Conclusions: </strong>Compared with OG, LG is associated with better surgical and long-term outcomes in Siewert type II/III AEG. LG is a safe and feasible option for treating Siewert type II/III AEG. However, studies with large sample sizes, long follow-up periods, and rigorous designs are needed for verification.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":"39 5-6","pages":"210-223"},"PeriodicalIF":2.7,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9366173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Digestive Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1